Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis (LN)
Status:
Terminated
Trial end date:
2018-01-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the safety and tolerability of ixazomib when
administered as multiple oral doses at escalating dose levels in participants with lupus
nephritis.